Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RAD54L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPP38 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSNK2A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZSCAN31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELAVL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLEKHA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
GPATCH8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLDIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR89A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSEN15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTRR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on